Skip to main content
SpringerLink
Log in

Effect of finasteride in idiopathic hirsutism

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Increased 5α-reductase activity has been found in hair follicles of hirsute women, suggesting a pathogenetic role. The aim of the present study was to evaluate the effect of finasteride in the treatment of idiopathic hirsutism. Twenty-seven women with idiopathic hirsutism, aged 16–35 years, were treated for 6 months with finasteride, 5 mg once daily. Fourteen patients were on finasteride alone (group A), while the remaining received in addition an oral contraceptive (group B). Clinical, hormonal and biochemical evaluation were performed before, and after 3 and 6 months of treatment. Clinical evaluation was repeated 6 months after drug discontinuation in seven patients. Treatment was well tolerated by all patients; no side effects or adverse reactions were reported. A significant improvement of hirsutism was obtained by finasteride; clinical score observed at the 6th month of therapy was reduced from 11.71 ±2.23 to 7.92±1.81 (p<0.05) and from 14.92±6.13 to 9.3±2.75 (p<0.05) in group A and B, respectively. Clinical score in seven patients was still 8.61 ±2.28 (p<0.05) 6 months after the end of therapy. Finasteride treatment alone (group A) induced a slight increase, though not significant, in serum androgens; DHT and SHBG did not change. In group B (finasteride plus oral contraceptive) total testosterone and free testosterone showed no significant decrease; after 6 months of therapy DHT was reduced significantly, while SHBG levels were increased. These data demonstrate that 5α-reductase inhibition may be an effective treatment in women suffering from idiopathic hirsutism. This approach may be attractive due to the absence of adverse reactions, although the necessity of an adequate contraception should be kept in mind.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Biffignandi P., Massucchetti C., Molinatti G.M. Female hirsutism: pathophysiological consideration and therapeutic implications. Endocr. Rev. 5: 498, 1984.

    Article  PubMed  CAS  Google Scholar 

  2. Erkkola R., Ruutiainen K. Hirsutism: definitions and etiology. Ann. Med. 22: 99, 1990.

    Article  PubMed  CAS  Google Scholar 

  3. Serafini P., Lobo R.A. Increased 5α-reductase activity in idiopathic hirsutism women. J. Clin. Endocrinol. Metab. 43: 74, 1985.

    CAS  Google Scholar 

  4. Labrie F., Sugimoto Y., Luu-The V., Simard J., Lachance Y., Bachvarov D., Leblanc G., Durosher F., Paquet N. Structure of human type II 5α-reductase gene. Endocrinology 131: 1571, 1992.

    PubMed  CAS  Google Scholar 

  5. Thigpen A.E., Silver R.I., Guileyardo J.M., Casey M.L., McConnell J.D., Russel D.W. Tissue distribution and ontogeny of steroid 5α-reducstase isozyme expression. J. Clin. Invest. 92: 903, 1993.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Wilson J.D., Griffin J.E., Russel D.W. Steroid 5α-reductase 2 deficiency. Endocr. Rev. 14: 577, 1993.

    PubMed  CAS  Google Scholar 

  7. Thigpen A.E., Davis D.L., Gautier T., Imperato McGinley J., Russel DW. Brief Report: the molecular basis of steroid 5α-reductase deficiency in a large dominican kindred. N. Engl. J. Med. 327: 1216, 1992.

    Article  PubMed  CAS  Google Scholar 

  8. Peters D.H., Sorkin E.M. Finasteride. Drugs 46: 177, 1993.

    Article  PubMed  CAS  Google Scholar 

  9. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21: 1440, 1961.

    Article  PubMed  CAS  Google Scholar 

  10. Carr B.R., Breslau N.A., Givens C., Byrd W., Barnett-Hamm C., Marshburn P.B. Oral contraceptive pills, Gonadotropin-Releasing Hormone Agonist, or use in combination for treatment of hirsutism: a clinical research center study. J. Clin. Endocrinol. Metab. 80: 1169, 1995.

    PubMed  CAS  Google Scholar 

  11. Spritzer P., Billaud L., Thalabard J.C., Birman P., Mowszowicz I., Raux-Demay MC., Clair F., Kuttenn F., Mauvais-Jarvis P. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J. Clin. Endocrinol. Metab. 70: 642, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Cusan L., Dupont A., Gomez J.-L., Tremblay R., Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil. Steril. 61: 281, 1994.

    PubMed  CAS  Google Scholar 

  13. O’Brien R.C., Cooper M.E., Murray R.M.L., Seeman E., Thomas A.K., Jerums G. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism. J. Clin. Endocrinol. Metab. 72: 1008, 1991.

    Article  PubMed  Google Scholar 

  14. Nielsen P.G. Treatment of idiopathic hirsutism with spironolactone. Dermatologica 165: 194, 1982.

    Article  Google Scholar 

  15. Jones K.R., Katz M., Keyzer C., Gordon W. Effect of cyproterone acetate on rate of hair growth in hirsute females. Br. J. Dermatol. 105: 685, 1981.

    Article  PubMed  CAS  Google Scholar 

  16. Helfer E.L., Miller J.C., Rose L.I. Side effects of spironolactone therapy in the hirsute women. J. Clin. Endocrinol. Metab. 66: 208, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Wysowki D.K., Frieman J.P., Tourtelot J.B., Horton M.L. Fatal and non fatal hepatotoxicity associated with flutamide. Ann. Intern. Med. 118: 860, 1993.

    Article  Google Scholar 

  18. Wallace C., Lalor E.A., Chik C.L. Hepatotoxicity complicating Flutamide treatment of hirsutism. Ann. Intern. Med. 119: 1150, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Faloia E., Filipponi S., Mancini V., Morosini P., De Pirro R. Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism. J. Endocrinol. Invest. 16: 675, 1993.

    Article  PubMed  CAS  Google Scholar 

  20. Andreiko J.L., Monroe S.E., Jaffe R.B. Treatment of hirsutism with a gonadotropin-releasing hormon agonist (nafarelin). J. Clin. Endocrinol. Metab. 63: 854, 1986.

    Article  Google Scholar 

  21. Johansen J.S., Riis B.J., Hassager C., Moen M., Jacobson J., Christiansen C. The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J. Clin. Endocrinol. Metab. 67: 701, 1988.

    Article  PubMed  CAS  Google Scholar 

  22. Mellin T.N., Busch R.D., Rasmusson G.H. Azasteroid as inhibitors of testosterone 5α-reductase in mammalian skin. J. Steroid. Biochem. Mol. Biol. 44: 121, 1993.

    Article  PubMed  CAS  Google Scholar 

  23. Dallob A.L., Sadich N.S., Unger W., Lipert S., Geissler L.A., Gregoir S.L., Nguyen H.H., Moore E.C., Tanaka W.K. The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J. Clin. Endocrinol. Metab. 79: 703, 1994.

    PubMed  CAS  Google Scholar 

  24. Fruzzetti F., De Lorenzo D., Parrini D., Ricci G. Effect of finasteride, a 5α-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. J. Clin. Endocrinol. Metab. 79: 831, 1994.

    PubMed  CAS  Google Scholar 

  25. Wong I.L., Morris R.S., Chang L., Spahn M.A., Stanczyk F.Z., Lobo R.A. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J. Clin. Endocrinol. Metab. 80: 233, 1995.

    PubMed  CAS  Google Scholar 

  26. Moghetti P., Castello R., Magnani C.M., Tosi F., Negri C., Armanini D., Bellotti G., Muggeo M. Clinical and hormonal effect of the 5α-reductase inhibitor finasteride in hirsutism. J. Clin. Endocrinol. Metab. 79: 1115, 1994.

    PubMed  CAS  Google Scholar 

  27. Toscano V., Horton R. Circulating Dihydrotestosterone may not reflect peripheral formation. J. Clin. Invest. 79: 1653, 1987.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  28. Ciotta L., Cianci A., Calogero A.E., Palumbo M.A., Marietta E., Sciuto A., Palumbo G. Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism. Fertil. Steril. 64: 299, 1995.

    PubMed  CAS  Google Scholar 

  29. Tolino A., Petrone A., Sarnacchiaro F., Cirillo D., Ronsini S., Lombardi G., Nappi C. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil. Steril. 66: 61, 1996.

    PubMed  CAS  Google Scholar 

  30. Castello R., Tosi F., Perrone F., Negri C., Muggeo M., Moghetti P. Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal efects during a 1-year course of therapy and 1-year follow-up. Fertil. Steril. 66: 734, 1996.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica di Endocrinologia, Istituto di Medicina Clinica, University of Ancona, Ancona, Italy

    Emanuela Faloia M.D., S. Filipponi, V. Mancini, S. Di Marco & F. Mantero

Authors
  1. Emanuela Faloia M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Filipponi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Di Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Mantero
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faloia, E., Filipponi, S., Mancini, V. et al. Effect of finasteride in idiopathic hirsutism. J Endocrinol Invest 21, 694–698 (1998). https://doi.org/10.1007/BF03350800

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350800

Key-words

Search

Navigation